Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06332885 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Zephyr Valve Japan Post-Marketing Surveillance

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 12 words
    • Site contacts updated at 17 of 17 sites
  2. Study sites: 15 to 17v4
  3. Site details revised at 3 of 15 sitesv3
  4. Study sites: 10 to 15v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Pulmonx Corporation
4 trials monitored
See all monitored trials
COPD
1,119 trials monitored
See 34 trials at risk
This is a multicenter, prospective, observational surveillance enrolling 140 consecutive patients with severe emphysema who are candidates for bronchoscopic lung volume reduction using Zephyr Endobronchial Valve at up to 20 centers across Japan and followed for 12 months.
Trial Details
NCT Number NCT06332885
Lead Sponsor Pulmonx Corporation
Conditions
(from sponsor)		 Emphysema, COPD, Severe Emphysema
Related terms Emphysema, Pulmonary Disease, Chronic Obstructive
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov